Ovarian atypical proliferative (borderline) mucinous tumors: Gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive

International Journal of Gynecological Pathology

Volumn 25, Issue 1, 2006, Pages 83-89

  Vang, Russell ^a,e   Gown, Allen M ^b   Barry, Todd S ^b   Wheeler, Darren T ^c,d   Ronnett, Brigitte M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHENOPATH LABORATORIES   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Atypical proliferative mucinous; Endocervical like type; Gastrointestinal type; Immunohistochemistry; Ovary

Indexed keywords

CA 125 ANTIGEN; CYTOKERATIN; ESTROGEN RECEPTOR; MESOTHELIN; PROGESTERONE RECEPTOR; WT1 PROTEIN; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; CYSTADENOCARCINOMA; FEMALE; GASTROINTESTINAL TYPE OVARY TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MUCINOUS CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEROMUCINOUS TYPE OVARY TUMOR; CELL COUNT; CELL PROLIFERATION; CLASSIFICATION; COLLOID CARCINOMA; GASTROINTESTINAL TUMOR; METABOLISM; MIXED MULLERIAN TUMOR; PATHOLOGY; PHENOTYPE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA, MUCINOUS; CELL COUNT; CELL PROLIFERATION; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MIXED TUMOR, MULLERIAN; OVARIAN NEOPLASMS; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 33644830267     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000177125.31046.fd     Document Type: Article

References (24)

1. Dube V, Roy M, Plante M, et al. Mucinous ovarian tumors of mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int J Gynecol Pathol 2005;24:138-46.
2. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with "pseudomyxoma peritonei." Am J Surg Pathol 2000;24:1447-64.
3. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999;23:617-35.
4. Rodriguez IM, Irving JA, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol 2004;28:1311-8.
5. Rodriguez IM, Prat J. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol 2002;26:139-52.
6. Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 1988;61:340-8.
7. Shappell HW, Riopel MA, Smith Sehdev AE, et al. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002;26:1529-41.
8. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;23:397-409.
9. Longacre TA, McKenney JK, Tazelaar HD, et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (≥5-year) follow-up. Am J Surg Pathol 2005;29:707-23.
10. Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111-28.
11. Slomovitz BM, Caputo TA, Gretz HF 3rd, et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002;26:592-600.
12. Ronnett BM, Kajdacsy-Balla A, Gilks CB, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004;35:949-60.
13. Abu-Jawdeh GM, Jacobs TW, Niloff J, et al. Estrogen receptor expression is a common feature of ovarian borderline tumors. Gynecol Oncol 1996;60:301-7.
14. Shiohara S, Shiozawa T, Shimizu M, et al. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis. Cancer 1997;80:908-16.
15. Rutgers JL, Baergen RN. Mucin histochemistry of ovarian borderline tumors of mucinous and mixed-epithelial types. Mod Pathol 1994;7:825-8.
16. Rutgers JL, Bell DA. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types. Mod Pathol 1992;5:367-71.
17. Koshiyama M, Konishi I, Mandai M, et al. Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas. Correlation with clinicopathology and sex steroid receptor status. Virchows Arch 1995;425:603-9.
18. Lee KR, Nucci MR. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Int J Gynecol Pathol 2003;22:42-51.
19. Vang R, Gown AM, Barry TS, et al. Estrogen (ER) and progesterone receptor (PR) expression in ovarian mucinous tumors: Utility for distinction of primary tumors from metastases [abstract]. Mod Pathol 2005;18:207A.
20. Carano KS, Soslow RA. Immunophenotypic analysis of ovarian and testicular müllerian papillary serous tumors. Mod Pathol 1997;10:414-20.
21. Halperin R, Zehavi S, Dar P, et al. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas. Eur J Gynaecol Oncol 2001;22:292-6.
22. Heinrich JK, Bottcher-Luiz F, Andrade LL, et al. HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization. Int J Gynecol Cancer 2004;14:1078-85.
23. Lindgren PR, Cajander S, Backstrom T, et al. Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 2004;221:97-104.
24. Al-Hussaini M, Stockman A, Foster H, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 2004;44:109-15.